Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.